← Back to Search

I for Gastroesophageal Reflux Disease (GERD Trial)

N/A
Waitlist Available
Research Sponsored by University of South Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

GERD Trial Summary

The purpose of this study is to review pre-operative studies and patient evaluation reports and compare those with the results of the post-operative studies, patient evaluation reports and subjective patients' outcomes following laparoscopic surgery for gastroesophageal reflux disorder. This will allow us to evaluate how patients have benefited from the procedure.

Eligible Conditions
  • Gastroesophageal Reflux Disease

GERD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The objective of this study is to review pre-operative studies and evaluation reports and compare those with post-operative studies and evaluation reports to evaluate outcome following laparoscopic surgery for GERD.

GERD Trial Design

1Treatment groups
Experimental Treatment
Group I: IExperimental Treatment1 Intervention
This is a single arm study. All patients will be asked to complete questionnaires and have their medical charts reviewed.

Find a Location

Who is running the clinical trial?

University of South FloridaLead Sponsor
410 Previous Clinical Trials
185,408 Total Patients Enrolled
Alexander S Rosemurgy, M.D.Study DirectorUniversity of South Florida

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~82 spots leftby Apr 2025